Article metrics

Download PDFPDF

OP007/#276 Phase I study of mirvetuximab soravtansine (MIRV) and rucaparib for recurrent endometrial, ovarian, fallopian tube or primary peritoneal cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2023

AbstractFullPdf
Nov 202157021
Dec 202156010
Jan 20226508
Feb 20223403
Mar 20223103
Apr 20224107
May 202247018
Jun 202233012
Jul 20228209
Aug 20224808
Sep 20227005
Oct 202259014
Nov 20224003
Dec 20221603
Jan 20231703
Feb 20232003
Mar 202327010
Total7430140